Healthcare Industry News: RaySearch Laboratories
News Release - January 31, 2014
RaySearch Laboratories: First RayStation(R) Order in the United KingdomSTOCKHOLM--(Healthcare Sales & Marketing Network)--RaySearch Laboratories AB (publ.) has been awarded a contract to supply its RayStation® treatment planning system (TPS) to Tayside Cancer Centre, Ninewells Hospital & Medical School in Dundee, UK. Ninewells will be the first clinical installation of RayStation® in the United Kingdom.
Ninewells Hospital & Medical School is one of the largest teaching hospitals in Europe. It has a comprehensive regional cancer centre serving the Tayside region of Scotland. The centre offers all forms of cancer therapy and treats approximately 1400 new cancer patients annually. The radiotherapy department at Ninewells will replace its current TPS with RayStation®, as its treatment planning system for conventional 3D-CRT treatments, as well as more advanced treatments, such as IMRT and VMAT.
The order includes sophisticated solutions, such as multi-criteria optimization, enabling a more efficient treatment planning process. Multi-criteria optimization is a highly intuitive tool that lets the clinician evaluate the impact of changing different treatment priorities in real-time, which has a large potential to speed up the time-consuming plan optimization process. The radiotherapy department at Ninewells Hospital will also implement dose tracking and adaptive planning using the dedicated tools available in RayStation, as well as investigating biological optimization and evaluation.
“NHS Tayside made the decision to purchase RayStation® following a comprehensive NHS Scotland procurement and evaluation process. The process took into consideration TPS generic specifications, site specific requirements by Tayside Cancer Centre and the benefits the system will bring to the centre over and above the competing systems. We look forward to working with the RaySearch team to produce the best possible treatment plans for patients”, says Salam Souliman, Head of RT Physics at Ninewells Hospital.
“The UK is a highly important market for us. We established our UK sales and service office in the second half of 2013 and this has already resulted in the first customer order. Ninewells is an excellent clinic and we are of course thrilled that they have now become our first UK customer”, says Johan Löf CEO of RaySearch.
RayStation® integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron and proton therapy. The system is built on the latest software architecture and has a graphical user interface offering state-of-the-art usability.
RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are mainly sold through license agreements with leading partners such as Philips, Nucletron, IBA, Varian and Brainlab. To date, 15 products have been launched through partners and RaySearch’s software is used at over 2,300 clinics in more than 30 countries. In addition, RaySearch offers the proprietary treatment planning system RayStation® directly to clinics. RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the company is listed in the Small Cap segment on NASDAQ OMX Stockholm.
Source: RaySearch Laboratories
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.